blocking the binding of non-histone proteins to DNA. These proteins may include transcrip-48 tion factors that regulate gene expression or proteins that further modify the chromatin [2] .
49
While DNA hyper-and hypomethylation is commonly associated with gene under-and 50 over-expression, the effects of specific chromatin modifications are less clearly understood.
51
However, the scientific community has been making steady progress toward understanding 52 the effects of chromatin marks.
53
Heintzman, et al. [3] reported the association of enhancers and promoters with single H3K4me3, whereas TSSs are reported to have low H3K4me1 and high H3K4me3. tionally, five marks, including H3K4me1/2/3, can be used for predicting the TSSs [4] . A 59 third study concluded that H3K4me2 and H3K4me3 are characteristic marks of TSSs. In 60 addition, the same study indicated that "H3K4me1 signal was low but showed some evi-61 dence of enrichment further downstream from the TSS than H3K4me2 and H3K4me3" [5] .
62
In sum, the studies published in 2007 were not in agreement. Some studies suggested that more complex than the simple presence or absence of particular marks. Stretches of each 100 of the four marks appeared in most of the plots, approximately centered about the DHSs.
101
The overlapping stretch of H3K4me1 was usually the longest, followed by H3K4me2 and 102 H3K27ac (roughly equal in length), with the H3K4me3 usually being the shortest. When 103 plotted about a single enhancer, we observed that the four marks form a pyramidal shape.
104
These results confirm that the enhancer epigenetic signature is not defined by the presence 105 or absence of H3K4me1 (the single mark hypothesis), but by the arrangement of the four 106 marks around the enhancer (the multiple marks hypothesis).
107
Next, we sought to determine whether the pyramidal enhancer pattern would persist in 108 a large data set. However, we had no reference for how these signatures compare to the 109 epigenome as a whole. Therefore, we examined the distributions of the four marks around 110 500 segments (each is 500 bp long), spread uniformly throughout the human chromosome 1.
111
We refer to these sequences as control sequences. These random segments have low content 112 of the epigenetic marks, though the actual content varied somewhat between the mark types.
113
H3K4me1 and H3K4me2 appeared in approximately 30% of samples, whereas H3K27ac and
114
H3K4me3 appeared in approximately 15%.
115
The epigenetic signatures of 2000 active enhancers were profiled (Figure 2 ). We found 116 that each of the four chromatin marks was consistently present at active enhancers (80-95%).
117
Further, the enhancer regions were 3.1-fold more enriched with H3K4me1 than the control 1.8 folds, P-value = 9.838e −6 ; H2K4me2: 1.9 folds, P-value = 1.289e −6 ; H3K4me3: 2.0 folds,
172
P-value = 0.0007712; H3K27ac: 2.5 folds, P-value = 3.752e −7 ; fisher's exact test). These 173 results suggest that inactive enhancers exhibit a weaker, yet significant, version of the epi-
174
genetic signature of the tissue-specific active enhancers.
175
The H1-specific enhancers and the IMR90-specific enhancers have similar epigenetic 
185
In general, the densities observed in H1 are narrower that those observed in IMR90. Recall 186 that the signature of the IMR90-specific enhancers consists of these layers: H3K4me1 (the 187 widest), H3K4me2 and H3K27ac (roughly the same width), and H3K4me3 (the narrowest).
188
The signature of the H1-specific enhancers consists of these layers: H3K4me2 (the widest),
189
H3K4me1 and H3K27ac (roughly the same width), and H3K4me3 (the narrowest). The 190 two signatures differ in the relative order of the lower two layers (H3K4me1 and H3K4me2).
191
These results show that the epigenetic signatures of the H1-specific enhancers and the IMR90- pyramidal pattern. Therefore, we decided to repeat the experiment with a more precise 211 method for determining active promoters based on gene expression levels.
212
The second time, we chose ten promoters of genes with the highest expression (active 213 promoters) in IMR90 as well as ten promoters of unexpressed genes (inactive promoters).
214
The epigenetic plots made for the inactive promoters showed no apparent pattern, while each signature and (ii) how these marks were arranged around the TSS, i.e. the directionality.
220
The layers of the directional-pyramidal signature of the active promoters were: H3K4me2
221
(the broadest), H3K4me3, H3K27ac, and H3K4me1 (the narrowest). Recall that the layers of 222 the pyramidal signature of the active enhancers were: H3K4me1 (the broadest), H3K4me2,
223
H3K27ac, and H3K4me3 (the narrowest).
224
Additionally, we found that H3K4me2/3, and H3K27ac all encompassed the TSS- 
235
We compared the four epigenetic marks across the two sets. The active promoters showed 236 clear enrichment of these marks compared to the inactive promoters (H3K4me1: 1.9 folds, 237 P-value = 8.826e −07 ; H3K4me2: 2.3 folds, P-value = 5.033e −14 ; H3K4me3: 3.6 folds, P-value 238 < 2.2e −16 ; H3K27ac: 3.6 folds, P-value < 2.2 e −16; Fisher's exact test).
239
As expected, active promoters were also enriched with the four marks compared to the 240 control sequences (H3K4me1: 2.4 folds, P-value = 3.903e −16 ; H3K4me2: 3.1 folds, P-value 241 < 2.2e −16 ; H3K4me3: 6.0 folds, P-value < 2.2e −16 ; H3K27ac: 5.6 folds, P-value < 2.2e −16 ;
242
Fisher's exact test).
243
H3K4me1 around active promoters demonstrated a clear drop at the TSS (Figure 5a ).
244
This drop mirrored the H3K4me1 TSS breaks observed in the individual promoters.
245
The individual promoter regions show that certain epigenetic marks extend farther on 
262
Active promoters of the H1 cell line are not marked epigenetically
263
We studied the active promoters of the H1 cell line using the same procedure used in studying 
290
• Active promoters of IMR90 demonstrate a directional-pyramidal epigenetic signature.
291
H3K4me2 is the base of the pyramid. H3K4me3 and H3K27ac are the middle layers.
292
H3K4me1 is the top of the pyramid. Note that the directional-pyramidal signature of 293 active promoters is roughly the "inverse" of pyramidal signature of active enhancers with 294 regard to chromatin mark length.
295
• Chromatin marks in active IMR90 promoters are unevenly distributed about the TSS.
296
H3K4me2/3 and H3K27ac tend to be more present downstream of the TSS, whereas
297
H3K4me1 tends to be more present upstream, and often has a characteristic gap around 298 the TSS. This transcription-dependent directionality around the TSS suggests that these 299 marks are involved with the initiation of transcription.
300
• The epigenetic signature of the enhancers active in H1 (embryonic stem cell) is similar to 301 the signature of those active in IMR90. However, the promoters of genes active in H1 do 302 not show any recognizable epigenetic pattern consisting of the four studied marks.
303
• Inactive enhancers in IMR90 exhibit a residual epigenetic signature that resembles the 304 signature of active enhancers, whereas inactive IMR90 promoters do not exhibit any such 305 signature.
306
• The epigenetic signatures of active enhancers in non-repetitive regions and those in repet-307 itive regions are indistinguishable. As this signature is linked to enhancer activation, this 308 reinforces the notion that repetitive elements have significant regulatory function. As such,
309
we urge the scientific community to stop masking/ignoring repeats and to start studying 310 them.
311

Materials and Methods
312
Data 313 In this study, we used enhancers experimentally determined by Rajagopal et al. [9] . An 314 enhancer is defined as a DNase I hypersensitive site (DHS) where p300 binds "distal to were downloaded from the FANTOM5 project [17, 18, 11] .
327
Individual Enhancers
328
Individual enhancers (p300 binding sites overlapped by DHSs) were manually selected. For 329 each p300 binding site, the overlapping DHS was located. Then, segments representing 330 the four chromatin marks that overlapped the DHS were detected. These chromatin mark 331 segments were then plotted one on top of another as lines to easily determine how these 332 marks were distributed about the DHS (and by extension the enhancer).
333
Multi-Enhancers
334
Active enhancers were taken from a list of experimentally determined enhancers (p300 bind-335 ing sites overlapping DHSs and distal to known TSSs) [9] . Using a list of repetitive elements 336 in the human genome, these enhancers were separated into two sets: those found in repetitive 
Control Sequences
343
We constructed a set of control sequences by selecting 500 segments distributed uniformly 344 throughout the human chromosome one. Each segment is 500 bp long. The IMR90 chromatin 345 marks overlapping the control sequences were analyzed and summed as done previously.
346
Active and Inactive Enhancers
347
The eRNA (enhancer RNA) data was used for selecting a set of enhancers highly active in Initially, individual promoters were manually selected from a list of all human promoters.
358
These promoters were analyzed the same way as the individual enhancers, plotting the epi- 
Multi-Promoters
365
We determined the 100 most expressed genes and 100 unexpressed genes in a specific cell line 
